BackSierra Oncology Overview

Sierra Oncology Receivables

Latest receivables for SRRA: $270K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$270000.00
↑ 26.17% YoYΔ $56000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Sierra Oncology Receivables History

Loading

Sierra Oncology vs. peers: Receivables Comparison

Loading

Sierra Oncology Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sierra Oncology (SRRA) FAQ

As of the most recent data (March 2022), SRRA shows a receivables of $270K. That compares with $210K in the prior-year period — up 26.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SRRA's receivables is now $270K (was $210K) — a 26.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Sierra Oncology is outperforming or lagging.

Tracking SRRA's receivables over time shows whether Sierra Oncology is scaling, shrinking, or reshaping that part of the business. The current reading is $270K That compares with $210K in the prior-year period — up 26.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Sierra Oncology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $270K) with ownership activity and broader fundamentals.

Sierra Oncology's receivables is $270K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.